Evidence map›Paper›PMID 12769414›Full record

ArticleHealth care analysis : HCA : journal of health philosophy and policy2002

Evidence-based medicine as an instrument for rational health policy.

Nikola Biller-Andorno, Reidar K Lie, Ruud ter Meulen

Abstract read
PubMed Publisher
In one paragraph

Article in Health care analysis : HCA : journal of health philosophy and policy, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. An ethical analysis of international health priority-setting.Health care analysis : HCA : journal of health philosophy and policy · 2008
    Article
  6. Access to high cost medicines in Australia: ethical perspectives.Australia and New Zealand health policy · 2008
    Article
  7. Article
  8. Recognizing tacit knowledge in medical epistemology.Theoretical medicine and bioethics · 2006
    Article
  9. Wanted: a new ethics field for health policy analysis.Health care analysis : HCA : journal of health philosophy and policy · 2005
    Article
  10. Article
  11. Evidence-based medicine: why do opponents and proponents use the same arguments?Health care analysis : HCA : journal of health philosophy and policy · 2005
    Review
  12. Ethics, EBM, and hospital management.Journal of medical ethics · 2004
    Review
  13. Evidence-based medicine: excessive attraction to efficiency and certainty?Health care analysis : HCA : journal of health philosophy and policy · 2002
    Article
  14. The role of evidence in health policy making: a normative perspective.Health care analysis : HCA : journal of health philosophy and policy · 2002
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Nikola Biller-AndornoDepartment of Medical Ethics and History of Medicine, University of Goettingen, Germany. nbiller@gwdg.de
Reidar K Lie
Ruud ter Meulen

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This article tries to present a broad view on the values and ethical issues that are at stake in efforts to rationalize health policy on the basis of economic evaluations (like cost-effectiveness analysis) and randomly controlled clinical trials. Though such a rationalization is generally seen as an objective and 'value free' process, moral values often play a hidden role, not only in the production of 'evidence', but also in the way this evidence is used in policy making. For example, the definition of effectiveness of medical treatment or health care service is heavily dependent on dominant individual or social views about the goals of the particular treatment or service. There is also a concern that a reliance on EBM in health policy will occur at the expense of widely shared social values like equity and solidarity. Moreover, there is a concern that when economic considerations and rational procedures become more influential, various 'outside' groups third parties like insurance companies and policy makers will get a stronger influence on medical practice which may lead to a change in the patient-provider relationship. The authors conclude that social values and patient preference should be explicitly addressed when health policy making is based on economic and other scientific evidence.

Indexed as

Cost-Benefit AnalysisDrug IndustryEthics, MedicalEvidence-Based MedicineHealth Care RationingHealth PolicyHumansInsurance, HealthState MedicineUnited KingdomHealth Care and Public Health

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.